EP Wealth Advisors LLC purchased a new stake in Cigna Group (NYSE:CI - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm purchased 11,765 shares of the health services provider's stock, valued at approximately $3,243,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Brighton Jones LLC boosted its position in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock worth $1,032,000 after purchasing an additional 318 shares in the last quarter. Sivia Capital Partners LLC grew its holdings in shares of Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider's stock valued at $384,000 after buying an additional 109 shares during the period. NewEdge Advisors LLC increased its position in shares of Cigna Group by 4.5% in the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider's stock valued at $7,347,000 after buying an additional 958 shares in the last quarter. Treasurer of the State of North Carolina increased its position in shares of Cigna Group by 16.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider's stock valued at $49,204,000 after buying an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. acquired a new stake in Cigna Group during the 2nd quarter worth $163,000. Institutional investors own 86.99% of the company's stock.
Cigna Group Trading Up 0.6%
Shares of NYSE:CI opened at $276.19 on Friday. The firm has a market cap of $72.98 billion, a price-to-earnings ratio of 11.43, a PEG ratio of 0.95 and a beta of 0.29. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The company's fifty day simple moving average is $284.20 and its 200 day simple moving average is $281.38. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68.
Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts' consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company's revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the prior year, the business earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts forecast that Cigna Group will post 30.51 EPS for the current fiscal year.
Cigna Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Tuesday, September 8th. Cigna Group's payout ratio is 25.82%.
Insider Activity
In other news, CAO Jamie G. Kates sold 899 shares of the company's stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company's stock, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the transaction, the insider owned 27,256 shares of the company's stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 23,012 shares of company stock valued at $6,386,550 over the last ninety days. 0.60% of the stock is owned by insiders.
Analysts Set New Price Targets
CI has been the topic of several recent analyst reports. Sanford C. Bernstein lifted their target price on Cigna Group from $371.00 to $381.00 and gave the stock an "outperform" rating in a report on Thursday, July 9th. Jefferies Financial Group downgraded Cigna Group from a "buy" rating to a "hold" rating and lowered their price target for the stock from $336.00 to $307.00 in a report on Tuesday, August 4th. Raymond James Financial lowered Cigna Group from a "strong-buy" rating to an "outperform" rating and dropped their price target for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Barclays lifted their price objective on Cigna Group from $304.00 to $310.00 and gave the company an "equal weight" rating in a report on Friday, July 31st. Finally, Wells Fargo & Company boosted their price objective on Cigna Group from $305.00 to $307.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $339.45.
View Our Latest Research Report on CI
Cigna Group Company Profile
(
Free Report)
Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.